Should Doctors Be Allowed to Recommend Cannabis? An Australian Perspective

An Australian working party recommended granting legal exemptions for patients with specific medical conditions to use cannabis, even though cannabinoid drugs were not formally registered.

Hall, W D et al.·The Medical journal of Australia·2001·Preliminary EvidenceReview
RTHC-00106ReviewPreliminary Evidence2001RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Cannabis had been advocated as a treatment for nausea, vomiting, wasting, pain, and muscle spasms across cancer, HIV/AIDS, and neurological conditions. However, cannabinoid drugs were not registered for medical use in Australia, and the authors noted that a smoked plant product was unlikely to meet registration standards.

A New South Wales Working Party recommended a middle path: granting exemption from prosecution for patients who were medically certified to have specified conditions. The authors argued this approach deserved consideration by other Australian state and territory governments.

Key Numbers

No quantitative data were presented in this editorial.

How They Did This

This was a short editorial commentary reviewing the state of cannabis policy in Australia and the recommendations of a New South Wales government working party. It did not involve original data collection or systematic review methodology.

Why This Research Matters

This piece captured a moment when Australia was grappling with the gap between patient demand for cannabis as medicine and the regulatory frameworks that prohibited it. The recommendation for prosecution exemptions rather than full legalization represented a cautious, incremental approach that many countries would later adopt in various forms.

The Bigger Picture

Australia would eventually establish a medical cannabis access scheme in 2016 through the Therapeutic Goods Administration. This 2001 editorial shows that the policy conversation was already underway years before formal legislation, driven by patient advocacy and emerging clinical evidence from other countries.

What This Study Doesn't Tell Us

This was an opinion piece, not a systematic analysis of evidence. It represented the views of three authors and did not provide comprehensive data on efficacy or safety. The short format (two pages) limited the depth of policy analysis.

Questions This Raises

  • ?How did prosecution-exemption models compare with prescription-based models in terms of patient access and safety oversight?
  • ?Did incremental policy changes like this accelerate or delay the development of formal medical cannabis programs?

Trust & Context

Key Stat:
NSW Working Party recommended legal exemption for certified patients
Evidence Grade:
This is an editorial commentary without original data or systematic methodology, placing it at the preliminary evidence level.
Study Age:
Published in 2001, this predates Australia's 2016 medical cannabis scheme by 15 years.
Original Title:
Allowing the medical use of cannabis.
Published In:
The Medical journal of Australia, 175(1), 39-40 (2001)
Database ID:
RTHC-00106

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Did Australia eventually legalize medical cannabis?

Yes. In 2016, Australia passed federal legislation allowing access to medical cannabis through the Therapeutic Goods Administration, more than a decade after this editorial was published.

Why was smoked cannabis unlikely to be registered as medicine?

The authors noted that regulatory bodies generally require standardized pharmaceutical products, and a smoked plant product does not meet typical drug registration standards for dosing consistency, safety, and delivery method.

Read More on RethinkTHC

Cite This Study

RTHC-00106·https://rethinkthc.com/research/RTHC-00106

APA

Hall, W D; Degenhardt, L J; Currow, D. (2001). Allowing the medical use of cannabis.. The Medical journal of Australia, 175(1), 39-40.

MLA

Hall, W D, et al. "Allowing the medical use of cannabis.." The Medical journal of Australia, 2001.

RethinkTHC

RethinkTHC Research Database. "Allowing the medical use of cannabis." RTHC-00106. Retrieved from https://rethinkthc.com/research/hall-2001-allowing-the-medical-use

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.